Blog2018-03-04T18:00:55-05:00
2906, 2017

Modern medicine in space

By |June 29th, 2017|Categories: In the press|Comments Off on Modern medicine in space

What has modern medicine learnt from humans in space? Results are encouraging Aenean vitae neque est. Proin aliquam, lacus non ullamcorper elementum, diam eros faucibus orci, sed lobortis lectus urna egestas ligula. Morbi viverra, orci ac sodales consectetur, erat justo [...]

1806, 2017

New Investments and Approvals Spur the Development of Biologics

By |June 18th, 2017|Categories: Manufacturing, Research & Development|Tags: , , , , , |Comments Off on New Investments and Approvals Spur the Development of Biologics

Although still expensive to develop and produce, large molecules are rapidly taking over. by Susan Thompson, Technical Director at VxP Biologics For most of the previous century, much of pharmaceutical research focused on the development of small-molecule “blockbuster” drugs, which treated a wide variety of diseases for a great number [...]

1606, 2017

Development of Biologics – Monoclonal Antibodies

By |June 16th, 2017|Categories: Research & Development|Tags: , , , , , |Comments Off on Development of Biologics – Monoclonal Antibodies

Monoclonal antibody approval success rates vary widely, but are on the increase overall. by Raymond E Peck, CEO of VxP Biologics The human monoclonal antibody (mAb) sector has witnessed tremendous growth since its inception in the early 1980s. Despite a rocky start, new technologies in molecule generation spurred rapid development [...]

606, 2017

Sterile Injectables for Clinical Trials

By |June 6th, 2017|Categories: Manufacturing, Research & Development|Tags: , , , |Comments Off on Sterile Injectables for Clinical Trials

Growth continues, but logistical and regulatory hurdles limit worldwide supplies. by Susan Thompson, Technical Director at VxP Biologics The global market for sterile injectables continues to expand at an impressive rate. In 2015, this market was valued at $299.7 billion; and its compound annual growth rate (CAGR) is projected at [...]

405, 2017

Five Crucial Areas of Concern in Any GLP Lyophilization Process

By |May 4th, 2017|Categories: Parenteral & Lyophilized Clinical Trial Materials|Tags: , , , , |Comments Off on Five Crucial Areas of Concern in Any GLP Lyophilization Process

Although lyophilization (freeze-drying) is a costly, time-consuming process, it offers a number of major advantages over simpler dosage forms. by Raymond E Peck, CEO of VxP Biologics Tablets and capsules can create problems for patients with nausea or difficulty swallowing; syringes can carry risk of infection; and even certain drugs [...]

1811, 2016

What we know about the structures of human brain (and what we don’t)

By |November 18th, 2016|Categories: On-going research|Comments Off on What we know about the structures of human brain (and what we don’t)

What we know about the structures of human brain (and what we don't) Results are encouraging Aenean vitae neque est. Proin aliquam, lacus non ullamcorper elementum, diam eros faucibus orci, sed lobortis lectus urna egestas ligula. Morbi viverra, orci ac [...]

Go to Top